Article actualité

Les articles d'actualités, brèves, dépêches et news du moment.

Les articles plus construits doivent aller dans la section "Dossiers".

Croissy-Beaubourg et Montpellier, le 3 février 2015 - THERADIAG (ISIN : FR0004197747, Mnémonique : ALTER, éligible PEA-PME), société spécialisée dans le diagnostic in vitro et le théranostic, annonce la signature d'un accord cadre de service avec la société pharmaceutique UCB et la réalisation d'un premier projet concernant le traitement anti-TNF certolizumab pegol (Cimzia®)...

The UK House of Commons voted today to clear the way for fertility clinics to use controversial germline engineering techniques to create embryos with DNA from three people. If also approved by the House of Lords, the bill would enact an exception to the UK’s law against inheritable genetic modification, which is also prohibited by more than 40 other countries and several international...

Mercredi 4 février

10h00              Conseil des Ministres – Palais de l’Elysée

11h30              Déplacement au Salon des entrepreneurs – Palais des Congrès

15h00              Questions au Gouvernement – Assemblée nationale

17h00              Entretien avec la commission espace du parti socialiste – 21, rue...

LONDON, UK (GlobalData), 3 February 2015 - The French pharmaceutical market is forecast to grow at a tepid Compound Annual Growth Rate (CAGR) of 0.7% from $46.2 billion in 2014 to $48.2 billion by 2020, restricted by an increasing focus on generic drugs, according to research and consulting firm GlobalData.

The company’s latest report* states that France was a relatively late entrant to...

Disease outbreak news - 1 February 2015 - On 27 January 2015, the IHR National Focal Point of Canada notified WHO of 1 laboratory-confirmed case of human infection with avian influenza A(H7N9) virus. On January 30, 2015 a second individual, travelling to China with the index case, was laboratory confirmed to also have influenza A(H7N9) infection.

The two individuals flew from Hong Kong...

Vitrines Sociétés

Voir toutes les vitrines